Dr Mehta is a serial entrepreneur who has successfully brought new technologies from lab prototypes to market in biotechnology and energy storage. He has had two successful exits for his shareholders and raised millions of dollars from venture capital for his previous ventures, forged strategic partnerships with Fortune 500 companies and driven over $350M in licensing and sales revenues. He has experience in managing and growing successful ventures in life sciences including drug discovery and development, medical devices/diagnostics and in the field of advanced materials and energy storage. As the Executive Chair and co-founder of Pulmokine Inc, he led the business efforts in financing and licensing with transactions over $350M, supporting progress of a breakthrough new drug from concept to clinical trials, addressing a major unmet medical need in pulmonary hypertension. The drug successfully met its endpoints in Phase II clinical trials in Dec 2022 and Dr Mehta led the M&A process to successful exit in 2024. He is the author of the industry-leading biomedical technology commercialization text book and manual for bio-entrepreneurs (titled Commercializing Successful Biomedical Technologies.